Publication: 3473

Everolimus With or Without Bevacizumab in Advanced pNET: CALGB 80701 (Alliance)
      QxMD      Google Scholar   
Citation:
Endocr Relat Cancer vol 29 (6) 335-344
Year:
2022
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
11
Parents:
2290   2384  
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, UG1CA233180, UG1CA233290, UG1CA233337, U10CA180863 (CCTG), U10CA180888 (SWOG)  
Corr. Author:
 
Authors:
                       
Networks:
CA824, LAPS-CT018, LAPS-MA036, LAPS-MN026, LAPS-NY016, NY021, OR013   
Study
CALGB-80701
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
Pancreatic neuroendocrine tumor, everolimus, bevacizumab, clinical trial